CRISM Therapeutics Corporation
CRTX
Rank in Stocks
#29858
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Share Price
$0.11537675
Last synced: 2026-11-17
Market Cap
$6.26M
Change (1 day)
5.81%
Change (1 year)
-32.11%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CRISM Therapeutics Corporation (CRTX)
Category
Healthcare
Operating Margin for CRISM Therapeutics Corporation (CRTX)
Operating Margin as of November 2026 TTM: 0.00%
According to CRISM Therapeutics Corporation's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for CRISM Therapeutics Corporation from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -2,328.00% | -40.88% |
| 2023 | -3,937.87% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | - |
US
|
|
| 33.87% | - |
US
|
|
| -116.04% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CRISM Therapeutics Corporation's operating margin
What was CRISM Therapeutics Corporation's operating margin in 2025?
In 2025, CRISM Therapeutics Corporation's operating margin was 0.00%, compared with -2,328.00% in 2024.
How has CRISM Therapeutics Corporation's operating margin changed since 2020?
From 2020 to 2025, CRISM Therapeutics Corporation's operating margin was highest in 2025 (0.00%) and lowest in 2023 (-3,937.87%).
How does CRISM Therapeutics Corporation's operating margin compare with similar companies?
CRISM Therapeutics Corporation's operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.